TRI.AX Shariah Compliance
Screening Methodology: AAOIFI
DOUBTFUL
Last Updated: July 30, 2025
Report Source: 2025 2nd Quarter Report
TrivarX Ltd. Stock Analysis TRI.AX
TrivarX Ltd. engages in clinical research, product development, and early-stage commercialization of mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.
Read More TrivarX Ltd (TRI.AX) Chart
Key Statistics of TrivarX Ltd (TRI.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.03Volume
785.58KP/E Ratio (TTM)
-52 Week Range
Market Cap
25.38MAvg. Volume
549.50KDividend Yield
-Financial Metrics & Statements of TrivarX Ltd (TRI.AX)
FAQ's for TrivarX Ltd (TRI.AX)
- According to Musaffa’s Shariah screening methodology, TrivarX Ltd (TRI.AX) is currently classified as DOUBTFUL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.